303 related articles for article (PubMed ID: 18837053)
41. Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas.
Ohnishi A; Sawa H; Tsuda M; Sawamura Y; Itoh T; Iwasaki Y; Nagashima K
J Neuropathol Exp Neurol; 2003 Oct; 62(10):1052-9. PubMed ID: 14575240
[TBL] [Abstract][Full Text] [Related]
42. Presence of pluripotent CD133+ cells correlates with malignancy of gliomas.
Thon N; Damianoff K; Hegermann J; Grau S; Krebs B; Schnell O; Tonn JC; Goldbrunner R
Mol Cell Neurosci; 2010 Jan; 43(1):51-9. PubMed ID: 18761091
[TBL] [Abstract][Full Text] [Related]
43. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
44. Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.
Verma R; Chen X; Xin D; Luo Z; Ogurek S; Xin M; Rao R; Berry K; Lu QR
Cancer Res; 2023 Mar; 83(6):890-905. PubMed ID: 36634201
[TBL] [Abstract][Full Text] [Related]
45. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
[TBL] [Abstract][Full Text] [Related]
46. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.
Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D
Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787
[TBL] [Abstract][Full Text] [Related]
47. Differences in metabolism of fiber tract alterations in gliomas: a combined fiber density mapping and magnetic resonance spectroscopic imaging study.
Stadlbauer A; Hammen T; Buchfelder M; Bachmair J; Dörfler A; Nimsky C; Ganslandt O
Neurosurgery; 2012 Aug; 71(2):454-63. PubMed ID: 22517254
[TBL] [Abstract][Full Text] [Related]
48. Differential expression of S100 calcium-binding proteins characterizes distinct clinical entities in both WHO grade II and III astrocytic tumours.
Camby I; Lefranc F; Titeca G; Neuci S; Fastrez M; Dedecken L; Schäfer BW; Brotchi J; Heizmann CW; Pochet R; Salmon I; Kiss R; Decaestecker C
Neuropathol Appl Neurobiol; 2000 Feb; 26(1):76-90. PubMed ID: 10736069
[TBL] [Abstract][Full Text] [Related]
49. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas.
Liu B; Pang B; Hou X; Fan H; Liang N; Zheng S; Feng B; Liu W; Guo H; Xu S; Pang Q
Hum Pathol; 2014 Aug; 45(8):1752-8. PubMed ID: 24935062
[TBL] [Abstract][Full Text] [Related]
50. [Analysis of S100beta-v-erbB transgenic rats prone to brain tumors].
Yokoo H; Tanaka Y; Nobusawa S; Nakazato Y; Ohgaki H
Brain Nerve; 2009 Jul; 61(7):765-72. PubMed ID: 19618853
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
52. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
[TBL] [Abstract][Full Text] [Related]
53. Cyclin D1 expression in gliomas.
Cavalla P; Dutto A; Piva R; Richiardi P; Grosso R; Schiffer D
Acta Neuropathol; 1998 Feb; 95(2):131-5. PubMed ID: 9498046
[TBL] [Abstract][Full Text] [Related]
54. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas.
Hsu DW; Louis DN; Efird JT; Hedley-Whyte ET
J Neuropathol Exp Neurol; 1997 Aug; 56(8):857-65. PubMed ID: 9258255
[TBL] [Abstract][Full Text] [Related]
55. LGR5 is a proneural factor and is regulated by OLIG2 in glioma stem-like cells.
Mao XG; Song SJ; Xue XY; Yan M; Wang L; Lin W; Guo G; Zhang X
Cell Mol Neurobiol; 2013 Aug; 33(6):851-65. PubMed ID: 23793848
[TBL] [Abstract][Full Text] [Related]
56. Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms.
Trépant AL; Bouchart C; Rorive S; Sauvage S; Decaestecker C; Demetter P; Salmon I
Tumour Biol; 2015 Mar; 36(3):1943-53. PubMed ID: 25384509
[TBL] [Abstract][Full Text] [Related]
57. Deregulated expression of the clock genes in gliomas.
Chen Z; Liu P; Li C; Luo Y; Chen I; Liang W; Chen X; Feng Y; Xia H; Wang F
Technol Cancer Res Treat; 2013 Feb; 12(1):91-7. PubMed ID: 22905804
[TBL] [Abstract][Full Text] [Related]
58. Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis.
Colin C; Virard I; Baeza N; Tchoghandjian A; Fernandez C; Bouvier C; Calisti A; Tong S; Durbec P; Figarella-Branger D
Neuropathol Appl Neurobiol; 2007 Aug; 33(4):431-9. PubMed ID: 17442061
[TBL] [Abstract][Full Text] [Related]
59. Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas.
Okada M; Yano H; Hirose Y; Nakayama N; Ohe N; Shinoda J; Iwama T
Brain Tumor Pathol; 2011 Apr; 28(2):157-61. PubMed ID: 21312066
[TBL] [Abstract][Full Text] [Related]
60. RIZ1: a potential tumor suppressor in glioma.
Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]